ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
The post ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes appeared first on Investor's Business Daily.